Lexaria Bioscience (LEXX) Cash from Discontinued Operations (2020 - 2021)
Lexaria Bioscience's (LEXX) quarterly Cash from Discontinued Operations came in at 27333.0 in Q1 2021, down 50.9% quarter-over-quarter from 55667.0 in Q4 2020.
Lexaria Bioscience (LEXX) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends
Lexaria Bioscience has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting 27333.0 for Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -59.14 Mn |
| 10 | Lexaria Bioscience | 7.63 Mn | 2.11 Mn | 20,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2021 | 27,333.00 |
| Feb 28, 2021 | 27,333.00 |
| Nov 30, 2020 | 55,667.00 |
| Nov 30, 2020 | 55,667.00 |